Basal Insulin Analogues: Are They That Different?

Slideshow

Are basal insulin analogues all that different from each other in their glucose-lowering effects? According to a new study, not really. 

Reference: Madenidou AV, Paschos P, Karagiannis T, et al. Comparative benefits and harms of basal insulin analogues for type 2 diabetes: A systematic review and network meta-analysis. Ann Intern Med. 2018;169:165-174.

Related Videos
Related Content
Anjali Dixit, MD, MPH | Credit: Stanford Medicine

GLP-1 Receptor Agonists Not Linked to Post-Op Respiratory Complications

April 25th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: 2024 ACP Type 2 Diabetes Recommendations

April 19th 2024
Podcast
Close up of a scale depicting body weight. | Credit: iStock

Tirzepatide Shows Benefit in Obstructive Sleep Apnea, SURMOUNT-OSA Trial

April 17th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

April 17th 2024
Podcast
Florian Koutny, MD | Credit: ResearchGate

Poorly Controlled Type 1 Diabetes Associated with MASLD in Children, Adolescents

April 12th 2024
Article
Manufacturing Costs for Diabetes Medicines Could Likely Be Lower | Image Credit: Harvard University

Manufacturing Costs for Diabetes Medicines Could Likely Be Lower, Study Finds

April 4th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.